B cell-targeting strategies such as rituximab are widely used in B cell hematologic
malignancies, rheumatologic and musculoskeletal diseases and a variety of autoimmune …

Timely and accurate diagnostic testing is a critical component of the public health response
to coronavirus (CoV) disease 2019 (COVID-19). Antigen (Ag) tests are used widely in many …

Summary Background Lateral flow devices (LFDs) for rapid antigen testing are set to
become a cornerstone of SARS-CoV-2 mass community testing, although their reduced …

Point-of-care tests for SARS-CoV-2 could enable rapid rule-in and/or rule-out of COVID-19,
allowing rapid and accurate patient cohorting and potentially reducing the risk of nosocomial …

Objective To assess the performance of the SARS-CoV-2 antigen rapid lateral flow test (LFT)
versus polymerase chain reaction testing in the asymptomatic general population attending …

The identification and isolation of highly infectious SARS-CoV-2-infected individuals is an
important public health strategy. Rapid antigen detection tests (RADT) are promising tools …

Inspired by the role of cell-surface glycoproteins as coreceptors for pathogens, we report the
development of GlycoGrip: a glycopolymer-based lateral flow assay for detecting SARS-CoV …

Background Admissions are generally classified as COVID-19 hospitalizations if the patient
has a positive SARS-CoV-2 polymerase chain reaction (PCR) test. However, because 35 …

The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)‐caused COVID‐19
pandemic has rapidly escalated into the largest global health emergency, which pushes to …

ABSTRACT COVID-19 has brought unprecedented attention to the crucial role of
diagnostics in pandemic control. We compared severe acute respiratory syndrome …